A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study

MLA

V K, Sondak, et al. “A Phase II Evaluation of All-Trans-Retinoic Acid plus Interferon Alfa-2a in Stage IV Melanoma: A Southwest Oncology Group Study.” The Cancer Journal from Scientific American, vol. 5, no. 1, Apr. 1999. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........83bdfc0c7ab5074e6393eee6e62c5930&authtype=sso&custid=ns315887.

APA

V K, S., P Y, L., L E, F., W S, F., P, P., D R, G., S A, T., S P, B., & F L, M. (1999). A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study. The Cancer Journal from Scientific American, 5(1).

Chicago

V K, Sondak, Liu P Y, Flaherty L E, Fletcher W S, Periman P, Gandara D R, Taylor S A, Balcerzak S P, and Meyskens F L. 1999. “A Phase II Evaluation of All-Trans-Retinoic Acid plus Interferon Alfa-2a in Stage IV Melanoma: A Southwest Oncology Group Study.” The Cancer Journal from Scientific American 5 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........83bdfc0c7ab5074e6393eee6e62c5930&authtype=sso&custid=ns315887.